Blueprint Genetics
Uses Next Generation Sequencing (NGS) to perform diagnostics on genetic diseases
Blueprint Genetics has raised €20M across 3 funding rounds from 6 investors, most recently a Series A round in Aug 2017. Based in Helsinki, Finland; founded 2012; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€20M
€20,425,016
Funding rounds
3
Investors
6
distinct backers
Active since
2014-08
latest 2017-08
Funding by year
EUR raised per yearBlueprint Genetics — funding by year — interactive chart.
Data table
| Blueprint Genetics — funding by year | |
|---|---|
| 2014 | €6.4M |
| 2017 | €14M |
Signals
High confidenceRaise-next likelihood9
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood9
base rate 11% (2+ rounds)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2017-08-03 | Series A | €14M | Creathor Venture,Inventure,MedTech Innovation Partners,Pontos Group,Stanford University | View deal → |
| 2014-09-01 | Other | €3.5M | — | View deal → |
| 2014-08-01 | Seed | €2.9M | Inventure | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Iceye€1.5BFinland · Space
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
Global coverage: FundingData